A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.

نویسندگان

  • Neville K Kisalu
  • Azza H Idris
  • Connor Weidle
  • Yevel Flores-Garcia
  • Barbara J Flynn
  • Brandon K Sack
  • Sean Murphy
  • Arne Scho N
  • Ernesto Freire
  • Joseph R Francica
  • Alex B Miller
  • Jason Gregory
  • Sandra March
  • Hua-Xin Liao
  • Barton F Haynes
  • Kevin Wiehe
  • Ashley M Trama
  • Kevin O Saunders
  • Morgan A Gladden
  • Anthony Monroe
  • Mattia Bonsignori
  • Masaru Kanekiyo
  • Adam K Wheatley
  • Adrian B McDermott
  • S Katie Farney
  • Gwo-Yu Chuang
  • Baoshan Zhang
  • Natasha Kc
  • Sumana Chakravarty
  • Peter D Kwong
  • Photini Sinnis
  • Sangeeta N Bhatia
  • Stefan H I Kappe
  • B Kim Lee Sim
  • Stephen L Hoffman
  • Fidel Zavala
  • Marie Pancera
  • Robert A Seder
چکیده

Development of a highly effective vaccine or antibodies for the prevention and ultimately elimination of malaria is urgently needed. Here we report the isolation of a number of human monoclonal antibodies directed against the Plasmodium falciparum (Pf) circumsporozoite protein (PfCSP) from several subjects immunized with an attenuated Pf whole-sporozoite (SPZ) vaccine (Sanaria PfSPZ Vaccine). Passive transfer of one of these antibodies, monoclonal antibody CIS43, conferred high-level, sterile protection in two different mouse models of malaria infection. The affinity and stoichiometry of CIS43 binding to PfCSP indicate that there are two sequential multivalent binding events encompassing the repeat domain. The first binding event is to a unique 'junctional' epitope positioned between the N terminus and the central repeat domain of PfCSP. Moreover, CIS43 prevented proteolytic cleavage of PfCSP on PfSPZ. Analysis of crystal structures of the CIS43 antigen-binding fragment in complex with the junctional epitope determined the molecular interactions of binding, revealed the epitope's conformational flexibility and defined Asn-Pro-Asn (NPN) as the structural repeat motif. The demonstration that CIS43 is highly effective for passive prevention of malaria has potential application for use in travelers, military personnel and elimination campaigns and identifies a new and conserved site of vulnerability on PfCSP for next-generation rational vaccine design.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites.

We produced a hybridoma secreting an immunoglobulin G1 monoclonal antibody against the circumsporozoite protein of the human malaria parasite Plasmodium malariae (Uganda 1/CDC). The monoclonal antibody produces a circumsporozoite precipitation reaction when incubated with viable sporozoites of P. malariae and reacts at high titers with heat-fixed sporozoites in an indirect immunofluorescent ant...

متن کامل

Heat shock factor 5 is essential for spermatogenesis in mice: Detected by a new monoclonal antibody

Objective(s): Here, we examined the function of our produced monoclonal antibody (mAb10C3) to recognize one of the most important members of the HEAT shock factor family, Hsf5, in embryonic development and in spermatogenic cells of adult mouse testis.Materials and Methods: The targeting effects of mAb10C3 were investigated by immunohisto...

متن کامل

Monoclonal Antibodies as Therapeutic Agents: Advances and Challenges

Despite the major advances in conventional forms of treatment (i.e. surgical techniques, radiotherapy and chemotherapy) and improved survival rates, cancer is still the second leading cause of death in developing countries. One major limitation of cytotoxic drugs and radiation in the treatment of cancer patients is their inability to discriminate between malignant and normal tissues. This in tu...

متن کامل

تولید مونوکلونال آنتی بادی علیه پروتئین سطحی شماره 2 مروزوئیت( MSP-2) و بررسی ایمنی زایی دومن های مختلف این مولکول

Background: Plasmodiom falciparum MSP-2 is taken into accout as one of the candidates of vaccine agaist malaria and various studies indicated immunizing effect of different domains of the molecule. Monoclonal antibody against MSP-2 is a confident and definite method to confirm this Immunization. Materials and Methods: P. falciparum Parasite was Prepared in a Culture in CludingRPMI1640 and Schi...

متن کامل

A Novel mAb against a Human CD34 Peptide Reacts with the Native Protein on CD34+ Cells

Background: Human CD34 is a transmembrane glycoprotein which is expressed in human hematopoietic stem cells (HSCs) and the small- vessel endothelial cells of a variety of tissues. CD34 plays a critical role as a marker for diagnosis and classification of leukemia. Anti CD34 antibodies are used for isolation and purification of HSCs from bone marrow, peripheral blood and cord blood. Objective: ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Nature medicine

دوره   شماره 

صفحات  -

تاریخ انتشار 2018